These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25411626)

  • 1. Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients.
    Iwata M; Matsushita Y; Fukuda K; Wakura T; Okabe K; Koshimizu Y; Fukushima Y; Kobashi C; Yamazaki Y; Honoki H; Suzuki H; Kigawa M; Tobe K
    J Diabetes Investig; 2014 Sep; 5(5):570-80. PubMed ID: 25411626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes.
    Funakoshi S; Fujimoto S; Hamasaki A; Fujiwara H; Fujita Y; Ikeda K; Takahara S; Nagashima K; Hosokawa M; Seino Y; Inagaki N
    J Diabetes Investig; 2011 Aug; 2(4):297-303. PubMed ID: 24843502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial serum C-peptide value is the optimal index to identify patients with non-obese type 2 diabetes who require multiple daily insulin injection: Analysis of C-peptide values before and after short-term intensive insulin therapy.
    Fujiwara D; Takahashi K; Suzuki T; Shii M; Nakashima Y; Takekawa S; Yoshida A; Matsuoka T
    J Diabetes Investig; 2013 Nov; 4(6):618-25. PubMed ID: 24843717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reliable serum C-peptide index for the selection of an insulin regimen to achieve good glycemic control in obese patients with type 2 diabetes: an analysis from a short-term study with intensive insulin therapy.
    Suzuki T; Takahashi K; Fujiwara D; Shii M; Takekawa S; Matsuoka T
    Diabetol Int; 2016 Sep; 7(3):235-243. PubMed ID: 30603269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUIT, secretory units of islets in transplantation: An index for therapeutic management of islet transplanted patients and its application to type 2 diabetes.
    Yamada Y; Fukuda K; Fujimoto S; Hosokawa M; Tsukiyama K; Nagashima K; Fukushima M; Suzuki H; Toyoda K; Sassa M; Funakoshi S; Inagaki N; Taniguchi A; Sato TS; Matsumoto S; Tanaka K; Seino Y
    Diabetes Res Clin Pract; 2006 Dec; 74(3):222-6. PubMed ID: 16707190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.
    Saisho Y; Kou K; Tanaka K; Abe T; Kurosawa H; Shimada A; Meguro S; Kawai T; Itoh H
    Endocr J; 2011; 58(4):315-22. PubMed ID: 21415555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
    Fujita Y; Kozawa J; Iwahashi H; Yoneda S; Uno S; Yoshikawa A; Okita K; Eguchi H; Nagano H; Imagawa A; Shimomura I
    Endocr J; 2015; 62(4):329-37. PubMed ID: 25740613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity in patients with type 2 diabetes.
    Kitamura A; Kurajoh M; Miki Y; Kakutani Y; Yamazaki Y; Ochi A; Morioka T; Mori K; Shoji T; Emoto M
    J Diabetes Investig; 2024 Oct; 15(10):1500-1509. PubMed ID: 39078414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
    Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
    Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus.
    Wakasaki H; Shono T; Nakao R; Yamamoto S; Minaga T; Fukuda S; Matsumoto R; Ohoshi T; Naka K; Nanjo K
    Intern Med; 2020; 59(18):2229-2235. PubMed ID: 32938850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of simple indices of graft function after islet transplantation.
    Caumo A; Maffi P; Nano R; Luzi L; Hilbrands R; Gillard P; Jacobs-Tulleneers-Thevissen D; Secchi A; Keymeulen B; Pipeleers D; Piemonti L
    Transplantation; 2011 Oct; 92(7):815-21. PubMed ID: 21836536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study.
    Ghasemi A; Tohidi M; Derakhshan A; Hasheminia M; Azizi F; Hadaegh F
    Acta Diabetol; 2015 Oct; 52(5):905-15. PubMed ID: 25794879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory units of islets in transplantation index is a useful clinical marker to evaluate the efficacy of sitagliptin in treatment of type 2 diabetes mellitus.
    Kubota A; Matsuba I; Saito T; Nabe K; Seino Y
    J Diabetes Investig; 2011 Oct; 2(5):377-80. PubMed ID: 24843517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus.
    Iwamoto Y; Kimura T; Tatsumi F; Sugisaki T; Kubo M; Nakao E; Dan K; Wamata R; Iwamoto H; Takahashi K; Sanada J; Fushimi Y; Katakura Y; Shimoda M; Nakanishi S; Mune T; Kaku K; Kaneto H
    Front Endocrinol (Lausanne); 2022; 13():871660. PubMed ID: 35574023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between higher urinary normetanephrine and insulin resistance in a Japanese population.
    Murabayashi M; Daimon M; Murakami H; Fujita T; Sato E; Tanabe J; Matsuhashi Y; Takayasu S; Yanagimachi M; Terui K; Kageyama K; Tokuda I; Sawada K; Ihara K
    PLoS One; 2020; 15(2):e0228787. PubMed ID: 32053635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes.
    Ito R; Fukui T; Hayashi T; Osamura A; Ohara M; Hara N; Higuchi A; Yamamoto T; Hirano T
    Drugs R D; 2015 Sep; 15(3):245-51. PubMed ID: 26224337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting C-peptide and Related Parameters Characterizing Insulin Secretory Capacity for Correctly Classifying Diabetes Type and for Predicting Insulin Requirement in Patients with Type 2 Diabetes.
    Becht FS; Walther K; Martin E; Nauck MA
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):148-56. PubMed ID: 26824281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.
    Xiang H; Yang C; Xiang T; Wang Z; Ge X; Li F; Su Y; Chen H; Huang X; Zeng Q
    Stem Cells Transl Med; 2016 May; 5(5):651-7. PubMed ID: 27025691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of various simple insulin sensitivity and beta-cell function indices in lean hyperandrogenemic and normoandrogenemic young hirsute women.
    Altuntas Y; Bilir M; Ozturk B; Gundogdu S
    Fertil Steril; 2003 Jul; 80(1):133-42. PubMed ID: 12849815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.